PharmaCyte Biotech Inc (PMCB)
2.39
-0.05
(-2.05%)
USD |
NASDAQ |
Mar 28, 16:00
2.41
+0.02
(+0.84%)
After-Hours: 20:00
PharmaCyte Biotech Price to Book Value: 0.6448 for March 28, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
March 28, 2024 | 0.6448 |
March 27, 2024 | 0.6583 |
March 26, 2024 | 0.6583 |
March 25, 2024 | 0.6691 |
March 22, 2024 | 0.6583 |
March 21, 2024 | 0.6502 |
March 20, 2024 | 0.6421 |
March 19, 2024 | 0.5774 |
March 18, 2024 | 0.5423 |
March 15, 2024 | 0.5261 |
March 14, 2024 | 0.554 |
March 13, 2024 | 0.5378 |
March 12, 2024 | 0.535 |
March 11, 2024 | 0.5459 |
March 08, 2024 | 0.5595 |
March 07, 2024 | 0.5568 |
March 06, 2024 | 0.5513 |
March 05, 2024 | 0.5513 |
March 04, 2024 | 0.5568 |
March 01, 2024 | 0.5649 |
February 29, 2024 | 0.5703 |
February 28, 2024 | 0.5703 |
February 27, 2024 | 0.5486 |
February 26, 2024 | 0.5649 |
February 23, 2024 | 0.5595 |
Date | Value |
---|---|
February 22, 2024 | 0.5595 |
February 21, 2024 | 0.5595 |
February 20, 2024 | 0.5595 |
February 16, 2024 | 0.5622 |
February 15, 2024 | 0.5676 |
February 14, 2024 | 0.5731 |
February 13, 2024 | 0.5568 |
February 12, 2024 | 0.5894 |
February 09, 2024 | 0.6084 |
February 08, 2024 | 0.5894 |
February 07, 2024 | 0.6016 |
February 06, 2024 | 0.5894 |
February 05, 2024 | 0.5894 |
February 02, 2024 | 0.6057 |
February 01, 2024 | 0.6016 |
January 31, 2024 | 0.5948 |
January 30, 2024 | 0.5272 |
January 29, 2024 | 0.5249 |
January 26, 2024 | 0.5132 |
January 25, 2024 | 0.5296 |
January 24, 2024 | 0.5132 |
January 23, 2024 | 0.5179 |
January 22, 2024 | 0.5108 |
January 19, 2024 | 0.5436 |
January 18, 2024 | 0.5366 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3297
Minimum
Jul 28 2023
18.53
Maximum
Jan 31 2020
4.326
Average
1.693
Median
Nov 27 2020
Price to Book Value Benchmarks
CEL-SCI Corp | 8.150 |
AIM ImmunoTech Inc | 1.050 |
IGC Pharma Inc | 2.816 |
NovaBay Pharmaceuticals Inc | 0.1351 |
Protalix BioTherapeutics Inc | 2.742 |
Price to Book Value Related Metrics
PS Ratio | 716.07 |
Price | 2.39 |
Earnings Yield | -50.21% |
Market Cap | 20.23M |